Cannabinoids prevent the effects of a footshock followed by situational reminders on emotional processing

Neuropsychopharmacology

Volumn 39, Issue 12, 2014, Pages 2709-2722

  Korem, Nachshon ^a   Akirav, Irit ^a  

^a UNIVERSITY OF HAIFA   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; BENZOXAZINE DERIVATIVE; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; GLUCOCORTICOID RECEPTOR; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE;

ANIMAL; ASSOCIATION; BRAIN; DEPTH PERCEPTION; DISEASE MODEL; DRUG EFFECTS; ELECTRIC SHOCK; EMOTION; LONG TERM POTENTIATION; MALE; METABOLISM; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REINFORCEMENT; SPRAGUE DAWLEY RAT; STARTLE REFLEX; STRESS DISORDERS, POST-TRAUMATIC;

ANIMALS; BENZOXAZINES; BRAIN; CANNABINOID RECEPTOR AGONISTS; CANNABINOIDS; CUES; DISEASE MODELS, ANIMAL; ELECTROSHOCK; EMOTIONS; EXTINCTION, PSYCHOLOGICAL; LONG-TERM POTENTIATION; MALE; MORPHOLINES; NAPHTHALENES; NEURONAL PLASTICITY; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, GLUCOCORTICOID; REFLEX, STARTLE; SPACE PERCEPTION; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84936763125     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.132     Document Type: Article

References (72)

1. Abush H, Akirav I (2010). Cannabinoids modulate hippocampal memory and plasticity. Hippocampus 20:1126-1138.
2. Abush H, Akirav I (2013). Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory. Neuropsychopharmacology 38:1521-1534.
3. Ahima RS, Harlan RE (1990). Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system. Neuroscience 39:579-604.
4. Akirav I (2013). Cannabinoids and glucocorticoids modulate emotional memory after stress. Neurosci Biobehav Rev 37:2554-2563.
5. Asmundson GJ, Katz J (2009). Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art. Depress Anxiety 26:888-901.
6. Atsak P, Roozendaal B, Campolongo P (2012). Role of the endocannabinoid system in regulating glucocorticoid effects on memory for emotional experiences. Neuroscience 204:104-116.
7. de Bitencourt RM, Pamplona FA, Takahashi RN (2013). A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers. Neuropharmacology 64:389-395.
8. Breivogel CS, Griffin G, Di Marzo V, Martin BR (2001). Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60:155-163.
9. Campolongo P, Roozendaal B, Trezza V, Hauer D, Schelling G, McGaugh JL et al (2009). Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc Natl Acad Sci USA 106:4888-4893.
10. Campos AC, Ferreira FR, da Silva WA, Guimarães FS (2012). Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms. Neurosci Lett 533:34-38.
11. Chen X, Li Y, Li S, Kirouac GJ (2012). Early fear as a predictor of avoidance in a rat model of post-traumatic stress disorder. Behav Brain Res 226:112-117.
12. Corral-Frias NS, Lahood RP, Edelman-Vogelsang KE, French ED, Fellous J-M (2013). Involvement of the ventral tegmental area in a rodent model of post-traumatic stress disorder. Neuropsychopharmacology 38:350-363.
13. Fraser GA (2009). The use of a synthetic cannabinoid in the management of treatment-Resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Ther 15:84-88.
14. French SJ, Totterdell S (2003). Individual nucleus accumbensprojection neurons receive both basolateral amygdala and ventral subicular afferents in rats. Neuroscience 119:19-31.
15. Ganon-Elazar E, Akirav I (2009). Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J Neurosci 29:11078.
16. Ganon-Elazar E, Akirav I (2012). Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress. Neuropsychopharmacology 37:456-466.
17. Ganon-Elazar E, Akirav I (2013). Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit. Psychoneuroendocrinology 38:1675-1687.
18. García-Gutiérrez MS, Ortega-Álvaro A, Busquets-García A, Pérez-Ortiz JM, Caltana L, Ricatti MJ et al (2013). Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors. Neuropharmacology 73:388-396.
19. Gill KM, Grace AA (2013). Differential effects of acute and repeated stress on hippocampus and amygdala inputs to the nucleus accumbens shell. Int J Neuropsychopharmacol 16:2013-2025.
20. Grillon C, Baas J (2003). A review of the modulation of the startle reflex by affective states and its application in psychiatry. Clin Neurophysiol 114:1557-1579.
21. Grillon C, Dierker L, Merikangas KR (1998). Fear-potentiated startle in adolescent offspring of parents with anxiety disordersf. Biol Psychiatry 44:990-997.
22. Grillon C, Morgan CA, Southwick SM, Davis M, Charney DS (1996). Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder. Psychiatry Res 64:169-178.
23. Heim C, Nemeroff CB (2009). Neurobiology of posttraumatic stress disorder. CNS Spectr 14:13-24.
24. Hill MN, Ho W-SV, Meier SE, Gorzalka BB, Hillard CJ (2005). Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala. Eur J Pharmacol 528:99-102.
25. Hill MN, McEwen BS (2009). Endocannabinoids: the silent partner of glucocorticoids in the synapse. Proc Natl Acad Sci USA 106:4579-4580.
26. Hill MN, McLaughlin RJ, Morrish AC, Viau V, Floresco SB, Hillard CJ et al (2009). Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology 34:2733-2745.
27. Hill MN, McLaughlin RJ, Pan B, Fitzgerald ML, Roberts CJ, TT-Y Lee et al (2011). Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J Neurosci 31:10506-10515.
28. Holstein DH, Vollenweider FX, Jäncke L, Schopper C, Csomor PA (2010). P50 suppression, prepulse inhibition, and startle reactivity in the same patient cohort suffering from posttraumatic stress disorder. J Affect Disord 126:188-197.
29. Imanaka A, Morinobu S, Toki S, Yamawaki S (2006). Importance of early environment in the development of post-traumatic stress disorder-like behaviors. Behav Brain Res 173:129-137.
30. Jovanovic T, Norrholm SD, Sakoman AJ, Esterajher S, Kozarić-Kovačić D (2009). Altered resting psychophysiology and startle response in Croatian combat veterans with PTSD. Int J Psychophysiol 71:264-268.
31. Katona I, Rancz EA, AcsÁdy L, Ledent C, Mackie K, HÁjos N et al (2001). Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21:9506-9518.
32. Kogan NM, Mechoulam R (2006). The chemistry of endocannabinoids. J Endocrinol Invest 29:3.
33. Lipschitz DS, Mayes LM, Rasmusson AM, Anyan W, Billingslea E, Gueorguieva R et al (2005). Baseline and modulated acoustic startle responses in adolescent girls with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry 44:807-814.
34. Lisboa SF, Reis DG, da Silva AL, Corrêa F, Guimaraes FS, Resstel L (2010). Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning. Int J Neuropsychopharmacol 13:1163-1173.
35. Lommen MJ, Engelhard IM, Sijbrandij M, van den Hout MA, Hermans D (2013). Pre-trauma individual differences in extinction learning predict posttraumatic stress. Behav Res Ther 51:63-67.
36. Louvart H, Maccari S, Ducrocq F, Thomas P, Darnaudéry M (2005). Long-term behavioural alterations in female rats after a single intense footshock followed by situational reminders. Psychoneuroendocrinology 30:316-324.
37. Maroun M, Akirav I (2008). Arousal and stress effects on consolidation and reconsolidation of recognition memory. Neuropsychopharmacology 33:394-405.
38. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG et al (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature 418:530-534.
39. Matar MA, Cohen H, Kaplan Z, Zohar J (2006). The effect of early poststressor intervention with sertraline on behavioral responses in an animal model of post-traumatic stress disorder. Neuropsychopharmacology 31:2610-2618.
40. Metzger LJ, Orr SP, Berry NJ, Ahern CE, Lasko NB, Pitman RK (1999). Physiologic reactivity to startling tones in women with posttraumatic stress disorder. J Abnorm Psychol 108:347.
41. Milad MR, Orr SP, Lasko NB, Chang Y, Rauch SL, Pitman RK (2008). Presence and acquired origin of reduced recall for fear extinction in PTSD: results of a twin study. J Psychiatr Res 42:515-520.
42. Milad MR, Quirk GJ (2002). Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420:70-74.
43. Milad MR, Wright CI, Orr SP, Pitman RK, Quirk GJ, Rauch SL (2007). Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol Psychiatry 62:446-454.
44. Moeller-Bertram T, Keltner J, Strigo IA (2012). Pain and post traumatic stress disorder-review of clinical and experimental evidence. Neuropharmacology 62:586-597.
45. Moreira FA, Wotjak CT (2010). Cannabinoids and anxiety. Curr Top Behav Neurosci 2:429-450.
46. Morena M, Hauer D, Ratano P, Scaccianoce S, Trezza V, Pecci C et al (2012). The endo-cannabinoid system and the regulation of memory consolidation for emotionally arousing experiences. FENS Abstract 6: p 0.45.14.
47. Mueller D, Porter JT, Quirk GJ (2008). Noradrenergic signaling in infralimbic cortex increases cell excitability and strengthens memory for fear extinction. J Neurosci 28:369-375.
48. Muschamp JW, Van't Veer A, Parsegian A, Gallo MS, Chen M, Neve RL et al (2011). Activation of CREB in the nucleus accumbens shell produces anhedonia and resistance to extinction of fear in rats. J Neurosci 31:3095-3103.
49. Nathan PJ, Cobb SR, Lu B, Bullmore ET, Davies CH (2011). Studying synaptic plasticity in the human brain and opportunities for drug discovery. Curr Opin Pharmacol 11:540-548.
50. Nestler EJ, Carlezon WA (2006). The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151-1159.
51. Neumeister A, Normandin MD, Pietrzak RH, Piomelli D, Zheng MQ, Gujarro-Anton A et al (2013). Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry 18:1034-1040.
52. O'Donnell P, Grace AA (1995). Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J Neurosci 15:3622-3639.
53. de Oliveira Alvares L, Engelke DS, Diehl F, Scheffer-Teixeira R, Haubrich J, de Oliveira Alvares L et al (2010). Stress response recruits the hippocampal endocannabinoid system for the modulation of fear memory. Learn Mem 17:202-209.
54. Olson VG, Rockett HR, Reh RK, Redila VA, Tran PM, Venkov HA et al (2011). The role of norepinephrine in differential response to stress in an animal model of posttraumatic stress disorder. Biol Psychiatry 70:441-448.
55. Ornitz EM, Pynoos RS (1989). Startle modulation in children with posttraumatic stress disorder. Am J Psychiatry 146:866-870.
56. Pamplona FA, Henes K, Micale V, Mauch CP, Takahashi RN, Wotjak CT (2011). Prolonged fear incubation leads to generalized avoidance behavior in mice. J Psychiatr Res 45:354-360.
57. Paxinos G, Watson C (1996). The Rat Brain in Stereotaxic Coordinates. Academic Press: San Diego, CA.
58. Pertwee RG, Howlett AC, Abood ME, Alexander S P H, Di Marzo V, Elphick MR et al (2010). International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 62:588-631.
59. Pitman RK, Van der Kolk BA, Orr SP, Greenberg MS (1990). Naloxone-reversible analgesic response to combat-related stimuli in posttraumatic stress disorder: a pilot study. Arch Gen Psychiatry 47:541-544.
60. Pynoos RS, Ritzmann RF, Steinberg AM, Goenjian A, Prisecaru I (1996). A behavioral animal model of posttraumatic stress disorder featuring repeated exposure to situational reminders. Biol Psychiatry 39:129-134.
61. Rademacher DJ, Meier SE, Shi L, Vanessa Ho W-S, Jarrahian A, Hillard CJ (2008). Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology 54:108-116.
62. Schwienbacher I, Fendt M, Richardson R, Schnitzler H-U (2004). Temporary inactivation of the nucleus accumbens disrupts acquisition and expression of fear-potentiated startle in rats. Brain Res 1027:87-93.
63. Segev A, Rubin AS, Abush H, Richter-Levin G, Akirav I (2013). Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression. Neuropsychopharmacology 39:919-933.
64. Sripada RK, Garfinkel SN, Liberzon I (2013). Avoidant symptoms in PTSD predict fear circuit activation during multimodal fear extinction. Front Hum Neurosci 7:672.
65. Stein DJ, Ipser JC, Seedat S (2006). Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev 1: CD002795.
66. Takahashi T, Morinobu S, Iwamoto Y, Yamawaki S (2006). Effect of paroxetine on enhanced contextual fear induced by single prolonged stress in rats. Psychopharmacology (Berl) 189:165-173.
67. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM (1997). Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83:393-411.
68. Vrana SR, Calhoun PS, McClernon FJ, Dennis MF, Lee ST, Beckham JC (2013). Effects of smoking on the acoustic startle response and prepulse inhibition in smokers with and without posttraumatic stress disorder. Psychopharmacology (Berl) 230:477-485.
69. Wang M, Hill MN, Zhang L, Gorzalka BB, Hillard CJ, Alger BE (2011). Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation. J Psychopharmacol 26:56-70.
70. Winters BD, Krüger JM, Huang X, Gallaher ZR, Ishikawa M, Czaja K et al (2012). Cannabinoid receptor 1-expressing neurons in the nucleus accumbens. Proc Natl Acad Sci USA 109:E2717-E2725.
71. Yehuda R, Flory JD, Southwick S, Charney DS (2006). Developing an agenda for translational studies of resilience and vulnerability following trauma exposure. Ann NY Acad Sci 1071:379-396.
72. Zohar J, Juven-Wetzler A, Sonnino R, Cwikel-Hamzany S, Balaban E, Cohen H (2011). New insights into secondary prevention in posttraumatic stress disorder. Dialogues Clin Neurosci 13:301.